January 23, 2023 03:45 AM ESTUpdated 04:15 AM
People
Bioregnum

What’s with Bris­tol My­ers’ R&D job cuts in New Jer­sey? They’re not say­ing much

It’s not un­usu­al these days to hear chat­ter about R&D lay­offs, with biotechs of all stripes cut­ting back and carv­ing out longer run­ways through cost …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Am­gen’s once-a-month obe­si­ty shot shows 20% weight loss af­ter a year

Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

Bris­tol My­ers re­veals more job cuts in New Jer­sey

A service from the Financial Times